A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia

NCT01808092 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

969

Enrollment

INDUSTRY

Sponsor class

Conditions

Nosocomial Pneumonia (NP)
Ventilator-associated Pneumonia (VAP)

Interventions

DRUG: ceftazidim-avibactam (CAZ-AVI, experimental product)
DRUG: meropenem (active comparator)

Sponsor

Pfizer